David Rice

Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA.

GSC Investment LLC provides investment services. It is a closed-end management investment company. The company's investment objectives are to generate both current income and capital appreciation through debt and to a lesser extent, equity investments by primarily investing in private middle market companies. The company was founded on March 21, 2007 and is headquartered in New York, NY.